Gallium-68-NOTA-Aca-BBN(7-14)

N/A

Report date: 2025/11/20 16:00:59

NME

Base Information

Drug NameGallium-68-NOTA-Aca-BBN(7-14)

Drug Alias Name68Ga-NOTA-Aca-bombesin(7-14)NOTA-Aca-BBN(7-14)-[68Ga]68Ga-NOTA-Aca-BBN(7-14)

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5]

Mechanisms of ActionGastrin releasing peptide receptor antagonists

TargetsGastrin releasing peptide receptor

Therapy Area/IndicationsDiagnostic agentsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPending

Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical College

China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of Medical Science & Peking Union Medical College

Inactive CompaniesNational Institute For Biomedical Imaging And Bioengineering (Nibib)

Active IndicationsDiagnostic agents

Inactive IndicationsGlioma

Other Information

ATC CodeN/A